Development and validation of a novel mitophagy-related gene prognostic signature for hepatocellular carcinoma based on immunoscore classification of tumor
Journal of Oncology Oct 28, 2021
Chen H, Wang J, Zeng R, et al. - Emerging evidence suggests an important role of mitophagy in the progression of hepatocellular carcinoma (HCC). Researchers herein investigated the correlation between mitophagy-related genes (MRGs) and HCC patients’ prognosis.
HCC patients from the TCGA cohort were categorized into two immune score groups according to the median immunoscore, while identifying 39 differential expression MRGs.
Eighteen survival-associated MRGs were screened out by using univariate analysis, and then, a prognosis model was constructed by applying the least absolute shrinkage and selection operator (LASSO) analysis; the model consisted of 9 MRGs (ATG7, ATG9A, BNIP3L, GABARAPL1, HTRA2, MAP1LC3B2, TFE3, TIGAR, and TOMM70).
In the prognostic model, significantly different overall survival was recorded in the high and low-risk groups.
The risk score was identified to be the independent factor for predicting the HCC patients’ prognosis.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries